$32.11
At close: Apr 15 EDT
$33.25
1.143.55%
Pre-Market: 8:24 AM EDT
Comments
Loading...
Legend Biotech Earnings Estimates, EPS & Revenue | NASDAQ:LEGN | Benzinga
Legend Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.310
Quarterly Revenue Estimate
$194.48M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$627.24M
Analyze the earnings history of Legend Biotech using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LEGN | Legend Biotech | -$0.16 | -$0.31 | — | — | $93.99M | $194.48M | — | — | 05/12/2025 | Get Alert |
| LEGN | Legend Biotech | -$0.40 | -$0.33 | -$0.15 | 54.55% | $79.46M | $178.93M | $186.52M | 4.24% | 03/11/2025 | Get Alert |
| LEGN | Legend Biotech | -$0.17 | -$0.42 | -$0.34 | 19.05% | $96.01M | $143.87M | $160.21M | 11.35% | 11/12/2024 | Get Alert |
| LEGN | Legend Biotech | -$0.57 | -$0.38 | -$0.05 | 86.84% | $73.33M | $126.59M | $186.52M | 47.34% | 08/09/2024 | Get Alert |
| LEGN | Legend Biotech | -$0.34 | -$0.34 | -$0.16 | 52.94% | $36.34M | $152.63M | $93.99M | -38.42% | 05/13/2024 | Get Alert |
| LEGN | Legend Biotech | -$0.41 | -$0.83 | -$0.40 | 51.81% | $27.63M | $86.35M | $79.46M | -7.97% | 03/11/2024 | Get Alert |
| LEGN | Legend Biotech | -$0.26 | -$0.65 | -$0.17 | 73.85% | $27.36M | $97.28M | $96.01M | -1.31% | 11/20/2023 | Get Alert |
| LEGN | Legend Biotech | -$0.62 | -$0.69 | -$0.57 | 17.39% | $11.97M | $53.20M | $73.33M | 37.84% | 08/15/2023 | Get Alert |
| LEGN | Legend Biotech | -$0.10 | — | -$0.34 | — | $50.04M | — | $36.34M | — | 05/18/2023 | Get Alert |
| LEGN | Legend Biotech | — | -$1.48 | -$1.40 | 5.41% | — | $144.65M | $117.00M | -19.11% | 03/30/2023 | Get Alert |
| LEGN | Legend Biotech | -$0.30 | -$0.46 | -$0.24 | 47.83% | $13.68M | $16.67M | $40.83M | 144.91% | 06/01/2022 | Get Alert |
| LEGN | Legend Biotech | -$0.22 | -$0.41 | -$0.30 | 26.83% | $40.78M | $14.22M | $38.99M | 174.23% | 03/18/2022 | Get Alert |
| LEGN | Legend Biotech | -$0.25 | -$0.35 | -$0.43 | -22.86% | $11.75M | $7.83M | $16.88M | 115.61% | 11/16/2021 | Get Alert |
| LEGN | Legend Biotech | -$0.63 | -$0.34 | -$0.32 | 5.88% | $11.60M | $9.13M | $20.23M | 121.61% | 08/23/2021 | Get Alert |
| LEGN | Legend Biotech | -$0.22 | -$0.35 | -$0.30 | 14.29% | $11.50M | $4.33M | $13.68M | — | 05/18/2021 | Get Alert |
| LEGN | Legend Biotech | — | -$0.28 | -$0.22 | 21.43% | — | $13.00M | $40.78M | 213.72% | 03/18/2021 | Get Alert |
| LEGN | Legend Biotech | -$0.14 | -$0.31 | -$0.25 | 19.35% | $17.67M | $13.00M | $11.75M | -9.64% | 11/16/2020 | Get Alert |
| LEGN | Legend Biotech | -$0.14 | -$0.30 | -$0.63 | -110.00% | $10.09M | $13.00M | $11.60M | -10.77% | 08/28/2020 | Get Alert |
Legend Biotech (LEGN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $-0.15 | $-0.33 | 54.5 % |
| Q3 | 2024-11-12 | $-0.34 | $-0.42 | 19.1 % |
| Q2 | 2024-08-09 | $-0.05 | $-0.38 | 86.8 % |
| Q1 | 2024-05-13 | $-0.16 | $-0.34 | 52.9 % |
Legend Biotech (LEGN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $186.52M | $178.93M | 4.24 % |
| Q3 | 2024-11-12 | $160.21M | $143.87M | 11.3 % |
| Q2 | 2024-08-09 | $186.52M | $126.59M | 47.3 % |
| Q1 | 2024-05-13 | $93.99M | $152.63M | -38.4 % |
FAQ
When is Legend Biotech (NASDAQ:LEGN) reporting earnings?
Legend Biotech (LEGN) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 11, 2025 for Q4.
What were the latest earnings per share (EPS) for Legend Biotech (NASDAQ:LEGN)?
The Actual EPS was $-0.15, which beat the estimate of $-0.33.
What were Legend Biotech’s (NASDAQ:LEGN) revenues?
The Actual Revenue was $186.5M, which beat the estimate of $178.9M.
Browse earnings estimates, EPS, and revenue on all stocks.